CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...
Phase 3
San Diego, California, United States and 69 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
San Diego, California, United States and 226 other locations
OR in combination with Hormonal Therapy in subjects with HR+, HER2- locally advanced and unresectable (Stage III) or metastatic (Stage IV) breast...
Phase 1
La Jolla, California, United States and 7 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Encinitas, California, United States and 317 other locations
Most physicians still use a one-size-fits-all approach to breast screening in which all women, regardless of their personal history, family ...
San Diego, California, United States and 10 other locations
The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer...
San Diego, California, United States and 5 other locations
This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer...
Phase 1
La Jolla, California, United States and 38 other locations
in combination with capecitabine in patients with HER2-negative breast cancer with brain metastases. Patients will be enrolled to r...
Phase 2
San Diego, California, United States and 15 other locations
oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin...
Phase 2
San Diego, California, United States and 23 other locations
This study is designed to compare the anti-tumor activity as well as the safety and efficacy of DS-8201a versus T-DM1 in HER2-positive, unre ...
Phase 3
San Diego, California, United States and 163 other locations
Clinical trials
Research sites
Resources
Legal